about
sameAs
Clinical management of children and young adults with heterozygous familial hypercholesterolaemia in the UKEruptive xanthomas as a cutaneous manifestation of hypertriglyceridemia: a case reportIsolation, characterization and hypolipidemic activity of ferulic acid in high-fat-diet-induced hyperlipidemia in laboratory ratsPolyhedral 3D structure of human plasma very low density lipoproteins by individual particle cryo-electron tomography1.Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitisHVC1 ameliorates hyperlipidemia and inflammation in LDLR-/- mice.Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemiaEpidemiology of cardiovascular disease in type 2 diabetes: the Indian scenario.Hypolipidaemic Effects of Gymnema sylvestre on High Fat Diet Induced Dyslipidaemia in Wistar RatsA review on the traditional Chinese medicinal herbs and formulae with hypolipidemic effect.Mig-6 plays a critical role in the regulation of cholesterol homeostasis and bile acid synthesis.Stair descending exercise using a novel automatic escalator: effects on muscle performance and health-related parameters.Lipid clinics are urgently required in the Iranian public health system.Association between CETP, MLXIPL, and TOMM40 polymorphisms and serum lipid levels in a Latvian population.Electronegative low-density lipoprotein increases C-reactive protein expression in vascular endothelial cells through the LOX-1 receptorImpact of probiotics on risk factors for cardiovascular diseases. A review.The regulation of alfalfa saponin extract on key genes involved in hepatic cholesterol metabolism in hyperlipidemic ratsGenetically defined hyperlipidemia.JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.A reversal of decreasing trends in population cholesterol levels in Västerbotten County, Sweden.Lipid-regulating effect of traditional chinese medicine: mechanisms of actions.Rare Variants Association Analysis in Large-Scale Sequencing Studies at the Single Locus LevelAnti-Atherogenic Properties of Allium ursinum Liophylisate: Impact on Lipoprotein Homeostasis and Cardiac Biomarkers in Hypercholesterolemic Rabbits.ACE Reduces Metabolic Abnormalities in a High-Fat Diet Mouse ModelAntisense oligonucleotides as therapeutics for hyperlipidaemias.Development of a 2',4'-BNA/LNA-based siRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In VivoThe potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins.Oxidative stress contributes to abnormal glucose metabolism and insulin sensitivity in two hyperlipidemia modelsApo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.Abdominal obesity, blood glucose and apolipoprotein B levels are the best predictors of the incidence of hypercholesterolemia (2001-2006) among healthy adults: the ATTICA study.Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia.Ezetimibe plus fenofibrate: a new combination therapy for the management of mixed hyperlipidaemia?Update on the clinical utility of fenofibrate in mixed dyslipidemias: mechanisms of action and rational prescribing.Antihyperlipidemic effects of ginger extracts in alloxan-induced diabetes and propylthiouracil-induced hypothyroidism in (rats).Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.A young infant with transient severe hypertriglyceridemia temporarily associated with meropenem administration: A case report and review of the literature.Omega-3 polyunsaturated fatty acids: a necessity for a comprehensive secondary prevention strategy.Effect of hypolipidemic treatment on glycemic profile in patients with mixed dyslipidemia.
P2860
Q24522271-E6A21B27-31E6-4507-BB0C-100142C47A72Q24633032-3D536EC3-2757-41F8-A884-FF21B4FE2AE5Q28817575-554BDB41-A292-49C2-804C-49F87F64B766Q30152743-182DFD03-3F91-48DC-8074-22AF6BC0CB3CQ33470002-4BDE3819-4AD4-443F-A7A8-897F113EFC53Q33582240-12C697A7-11DE-4899-8A46-DB4332C13F36Q33644452-ED7C8B3C-CDDB-490F-8FF9-42C196A1E045Q33674543-73D70306-A86F-4ACC-8A1F-7FEE02554693Q33832080-9C9A7ABA-E973-40A4-8FBC-044B5AEAF35CQ33942724-8452D9DA-C644-4268-9F29-3A8F87DDB698Q34389069-55DE1A6F-8B84-4165-AFA1-4FAE95F24FDEQ34598417-668C92D6-42A1-48F0-A53C-2D1D224D23CBQ34786612-BBE7643F-5369-4C5A-8281-8B15C18BE641Q34879561-25D6BE45-2B4D-433C-A270-C0E402FE53A2Q34947183-6DB29487-47FA-482F-B796-34C2EA600DCDQ35031383-A5DBD3C2-7B80-46E5-8EE1-7547400BE6F1Q35088651-457338CC-3CC1-4319-A612-13D149A8B6FDQ35753332-25533B5C-AD3F-4E53-91E5-964C6227D84AQ35808362-046594A7-44CB-4374-9FB0-C7347744B7C0Q35855620-8E7A7920-E9C2-4E18-9B78-0D8D4BDF4E5BQ35961350-20473FA0-D338-4D77-8AE5-BA2229C716B0Q36063830-64E1D01E-6AC8-4B9C-A5D8-2D67492369C3Q36102700-86CAE431-78FC-4D1F-B6B3-DF3C83AC3EA5Q36174272-F97F72CA-064E-4C55-91DF-19BFFCAEFC45Q36194069-91A3C789-5E1A-4596-A4EA-436A9E6D9CE4Q36299367-5D825CF1-86C7-413E-919F-2BDEE2030C0DQ36310311-8C6169E4-8F62-4472-B58E-C5855C053D0DQ36357787-5740C65A-DBD8-409A-9354-322CCDB61659Q36375364-DE5A9DF7-C2ED-4629-B1DC-B332B190F5B7Q36395720-4C6FBBD7-6E8F-4919-9E1D-BBC363CCA724Q36596847-8796AB1B-9794-424A-BAF8-67E534443B8FQ36628517-E6BEF653-7B29-4B18-9913-6A0062FC587EQ36744086-DB220555-1ED8-4216-9FCF-37068671451AQ36847314-4F3094A5-53AA-4920-9A18-E4F61255F3B1Q37019924-49282471-6427-456A-8D57-659F37DC69DAQ37035001-E240AA1D-2355-4BAC-B129-2154DCAEA556Q37254899-FAD7FFD1-93F4-4A70-988B-17AD38EC096BQ37300598-3FA99422-2623-4122-A39C-D60296337D06Q37367669-BB6CD2B1-A1E3-4223-B5A6-DE9AE37B859BQ37417770-61F0EB19-1785-41A6-B7E8-128C2714062F
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Dyslipidaemia
@ast
Dyslipidaemia
@en
Dyslipidaemia
@nl
type
label
Dyslipidaemia
@ast
Dyslipidaemia
@en
Dyslipidaemia
@nl
prefLabel
Dyslipidaemia
@ast
Dyslipidaemia
@en
Dyslipidaemia
@nl
P3181
P1433
P1476
Dyslipidaemia
@en
P2093
Paul Durrington
P304
P3181
P356
10.1016/S0140-6736(03)14234-1
P407
P577
2003-08-30T00:00:00Z